Literature DB >> 2228221

Aspergillus fumigatus complement inhibitor: production, characterization, and purification by hydrophobic interaction and thin-layer chromatography.

R G Washburn1, D J DeHart, D E Agwu, B J Bryant-Varela, N C Julian.   

Abstract

Aspergillus fumigatus has previously been shown to produce a soluble extracellular inhibitor of the alternative complement pathway, called Aspergillus complement inhibitor, or CI. We now report an efficient method for production of CI which relies on the fact that poorly conidiating cultures yielded CI activity with approximately sevenfold-higher potency than CI produced by conidiating cultures. CI from poorly conidiating cultures provided 50% inhibition of alternative pathway-mediated binding of 125I-labeled complement component C3 to cryptococcal blastoconidia at a mean concentration of 60 micrograms/ml. The ability of crude CI to inhibit the alternative complement pathway seemed to be independent of intact protein or polysaccharide structure, as evidenced by resistance of inhibitory activity to digestion by proteases, including subtilisin, alpha-chymotrypsin, papain, and pepsin as well as endoglycosidases F and H. Separation of the active inhibitory component of CI from contaminating materials contained in crude CI preparations was achieved by using Phenylsuperose hydrophobic interaction chromatography in a fast protein liquid chromatography system. The active material proved to be extremely hydrophobic, desorbing from the column only during elution with ethanol; it contained only 15% protein and 5% polysaccharide. Furthermore, results from preparative thin-layer chromatography indicated that lipids which comigrated with phosphatidylserine/phosphatidylinositol and phosphatidylethanolamine possessed significant complement-inhibitory activity. Taken together, these data suggested that phospholipids from A. fumigatus contributed to the functional activity of CI.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2228221      PMCID: PMC313690          DOI: 10.1128/iai.58.11.3508-3515.1990

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  32 in total

1.  A rapid method of total lipid extraction and purification.

Authors:  E G BLIGH; W J DYER
Journal:  Can J Biochem Physiol       Date:  1959-08

2.  Activation and binding of opsonic fragments of C3 on encapsulated Cryptococcus neoformans by using an alternative complement pathway reconstituted from six isolated proteins.

Authors:  T R Kozel; M A Wilson; G S Pfrommer; A M Schlageter
Journal:  Infect Immun       Date:  1989-07       Impact factor: 3.441

3.  Identification of C3d receptors on Candida albicans.

Authors:  R A Calderone; L Linehan; E Wadsworth; A L Sandberg
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

4.  An iC3b receptor on Candida albicans: structure, function, and correlates for pathogenicity.

Authors:  B J Gilmore; E M Retsinas; J S Lorenz; M K Hostetter
Journal:  J Infect Dis       Date:  1988-01       Impact factor: 5.226

5.  A comparative study of the lipids of a toxigenic & a non-toxigenic strain of Aspergillus flavus.

Authors:  S R Gupta; L Viswanathan; T A Venkitasubramanian
Journal:  Indian J Biochem       Date:  1970-06

Review 6.  Aspergillosis. The spectrum of the disease in 98 patients.

Authors:  R C Young; J E Bennett; C L Vogel; P P Carbone; V T DeVita
Journal:  Medicine (Baltimore)       Date:  1970-03       Impact factor: 1.889

7.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

8.  The release of intact oligosaccharides from specific glycoproteins by endo-beta-N-acetylglucosaminidase H.

Authors:  A L Tarentino; T H Plummer; F Maley
Journal:  J Biol Chem       Date:  1974-02-10       Impact factor: 5.157

9.  Activation of C3 and binding to Aspergillus fumigatus conidia and hyphae.

Authors:  T R Kozel; M A Wilson; T P Farrell; S M Levitz
Journal:  Infect Immun       Date:  1989-11       Impact factor: 3.441

10.  Effect of membrane phospholipids on activation of the alternative complement pathway.

Authors:  C Mold
Journal:  J Immunol       Date:  1989-09-01       Impact factor: 5.422

View more
  16 in total

Review 1.  Target recognition failure by the nonspecific defense system: surface constituents of pathogens interfere with the alternative pathway of complement activation.

Authors:  R D Horstmann
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

2.  Identification of 45 kD antigen in immune complexes of patients of allergic bronchopulmonary aspergillosis.

Authors:  T Madan; B Banerjee; P K Bhatnagar; A Shah; P U Sarma
Journal:  Mol Cell Biochem       Date:  1997-01       Impact factor: 3.396

Review 3.  Virulence factors of medically important fungi.

Authors:  L H Hogan; B S Klein; S M Levitz
Journal:  Clin Microbiol Rev       Date:  1996-10       Impact factor: 26.132

Review 4.  Aspergillus fumigatus and aspergillosis.

Authors:  J P Latgé
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

5.  Interactions between conidia of Aspergillus fumigatus and human complement component C3.

Authors:  J E Sturtevant; J P Latgé
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

6.  The Cu,Zn superoxide dismutases of Aspergillus flavus, Aspergillus niger, Aspergillus nidulans, and Aspergillus terreus: purification and biochemical comparison with the Aspergillus fumigatus Cu,Zn superoxide dismutase.

Authors:  M D Holdom; R J Hay; A J Hamilton
Journal:  Infect Immun       Date:  1996-08       Impact factor: 3.441

7.  The developmentally regulated alb1 gene of Aspergillus fumigatus: its role in modulation of conidial morphology and virulence.

Authors:  H F Tsai; Y C Chang; R G Washburn; M H Wheeler; K J Kwon-Chung
Journal:  J Bacteriol       Date:  1998-06       Impact factor: 3.490

8.  The opportunistic human pathogenic fungus Aspergillus fumigatus evades the host complement system.

Authors:  Judith Behnsen; Andrea Hartmann; Jeannette Schmaler; Alexander Gehrke; Axel A Brakhage; Peter F Zipfel
Journal:  Infect Immun       Date:  2007-11-26       Impact factor: 3.441

9.  Immune evasion by acquisition of complement inhibitors: the mould Aspergillus binds both factor H and C4b binding protein.

Authors:  G Vogl; I Lesiak; D B Jensen; S Perkhofer; R Eck; C Speth; C Lass-Flörl; P F Zipfel; A M Blom; M P Dierich; R Würzner
Journal:  Mol Immunol       Date:  2007-10-25       Impact factor: 4.407

10.  A component of the medicinal herb ephedra blocks activation in the classical and alternative pathways of complement.

Authors:  M Ling; S J Piddlesden; B P Morgan
Journal:  Clin Exp Immunol       Date:  1995-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.